Nutex Health Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 11 | Q4 11 | Q1 16 | Q2 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | 18,933.1 | 8,248.0 | 3,294.4 | 1,772.0 | – | – | – | – | – | – | 3,299.4 | 42.4 | 26.6 | 22.9 | 26.9 | 20.9 | 29.6 | – | – | – | – | – | – | – | – | – | 3.1 | 4.1 | 16.5 | 6.5 | 18.4 | 7.1 | 6.7 | |
| – | – | – | – | – | 0.0 | 15,756.5 | 105,650.3 | 786,865.4 | 278,852.7 | 135,068.2 | 4,366.8 | 2,384.1 | 1,165.8 | 741.0 | 752.2 | 895.0 | 1,259.6 | 14.7 | 10.0 | 9.2 | 9.9 | 7.5 | 6.5 | 4.3 | 6.4 | 3.5 | 1.4 | 0.6 | 0.5 | 0.3 | 0.1 | 0.6 | 0.3 | 0.4 | 1.0 | 0.8 | 1.3 | 0.8 | 1.4 | |
| – | – | – | – | – | – | 3,512.0 | 15,093.3 | 14,869.7 | 5,901.2 | 4,956.9 | 866.0 | 1,608.1 | 1,593.4 | 616.6 | 345.7 | 231.2 | 1,575.5 | 24.1 | 25.5 | 36.1 | 21.2 | 33.8 | 3.9 | 8.8 | 14.6 | 7.5 | 3.0 | 1.5 | 1.9 | 1.1 | 0.5 | 2.0 | 1.1 | 1.4 | 3.5 | 2.3 | 3.6 | 2.0 | 3.0 | |
| – | – | – | – | – | – | 15,756.5 | 105,650.4 | 786,865.7 | 278,853.4 | 135,069.7 | 4,368.0 | 2,384.8 | 1,166.5 | 742.8 | 754.2 | 895.4 | 1,259.5 | 14.7 | 10.0 | 9.5 | 10.1 | 7.5 | 6.4 | 4.3 | 6.4 | 3.6 | 1.5 | 0.7 | 0.6 | 0.3 | 0.1 | 61.5 | 0.4 | 0.4 | 0.9 | 0.6 | 1.2 | 0.6 | 1.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,939.2 | 3,054.6 | 39.0 | 22.6 | 18.0 | 19.1 | 14.8 | 15.7 | – | – | – | – | 12.9 | – | – | 27.7 | 2,259.1 | 1.1 | 1.1 | 3.2 | 1.8 | 3.8 | 1.8 | 2.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 263.1 | 45.6 | 30.0 | 22.4 | 16.7 | 39.0 | 126.7 | – | 26.1 | – | – | 2.2 | 8.0 | 7.8 | 4.0 | 9.9 | 4.2 | 4.8 | 2.5 | 4.4 | |
| – | – | – | – | – | -552,781.1% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | -0.4% | -0.3% | -0.2% | 0.0% | -0.6% | -0.6% | 0.4% | 2.2% | 3.3% | 4.5% | 6.0% | 2.6% | 0.8% | -2.6% | 3.8% | -7.2% | -3.8% | 44.8% | 12.5% | 12.9% | 25.2% | 10.1% | 23.8% | 20.8% | 39.5% | 22.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 36.4% | 40.0% | – | – | – | 96.3% | 71.6% | 54.2% | -1,274.5% | -1,724.7% | -878.6% | -194.6% | -32.7% | 7.6% | 27.2% | 22.9% | 29.4% | – | – | – | – | 51.9% | 50.5% | 44.2% | 17.9% | 8.8% | -6.0% | -4.4% | 11.6% | 16.0% | 17.3% | 20.9% | 23.2% | 40.9% | 48.8% | 51.4% | 55.0% | 50.8% | 47.5% | 51.3% | |
| -45.0% | -33.1% | – | – | – | -0.3% | -78.5% | 176.3% | -3,127.2% | -9,018.4% | -8,107.6% | -37,419.7% | -25,155.4% | -28,939.3% | -19,101.9% | -11,440.9% | -6,252.0% | 56.0% | 52.2% | 50.3% | 55.8% | 46.1% | 45.4% | 37.0% | -168.3% | -180.7% | -218.8% | -217.3% | -0.5% | -12.8% | -10.0% | -7.3% | -3.3% | 27.2% | 32.3% | 29.0% | 35.7% | 30.5% | 31.4% | 43.0% | |
| -25.2% | -15.0% | – | – | – | -20.1% | -126.6% | 558.0% | 9,540.1% | 8,464.4% | 7,622.5% | -1,200.6% | -575.3% | -464.8% | -358.3% | -237.6% | -10.0% | 38.2% | 34.7% | 37.7% | 40.4% | 36.7% | 36.0% | 22.0% | -173.0% | -189.0% | -224.5% | -215.4% | -8.0% | -18.5% | -15.8% | -13.7% | -14.1% | 10.9% | 10.8% | 6.3% | 11.6% | 7.3% | 11.0% | 21.2% | |
| – | – | – | – | – | -18.0% | -20.2% | -60.0% | -1,986.9% | – | – | – | – | – | -267.0% | -209.4% | -175.0% | -9.1% | -8.7% | -6.3% | 3.5% | 21.6% | 25.0% | 29.0% | 25.5% | 16.4% | 2.8% | -3.6% | 2.2% | -3.3% | -1.0% | 4.8% | 6.9% | 4.3% | 11.1% | 10.5% | 18.0% | 28.1% | 30.6% | 32.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -33.6% | -23.9% | – | – | – | – | -28.2% | 79.7% | 180.3% | 179.1% | 279.7% | -238.1% | -388.0% | -635.2% | -298.2% | -109.2% | -2.6% | 47.7% | 57.0% | 96.0% | 157.8% | 78.8% | 161.7% | 13.3% | -358.5% | -432.3% | -476.2% | -459.1% | -20.7% | -74.5% | -65.1% | -60.4% | -51.6% | 35.7% | 34.1% | 21.2% | 36.0% | 19.5% | 27.8% | 45.6% | |
| -29.3% | -18.5% | – | – | – | – | -25.7% | 70.8% | 120.2% | 112.1% | 157.6% | -119.2% | -168.2% | -193.2% | -83.7% | -49.1% | -2.0% | 13.3% | 49.8% | 83.5% | 140.1% | 22.9% | 139.5% | 8.0% | -91.1% | -96.0% | -102.5% | -97.5% | -3.9% | -11.5% | -10.1% | -9.0% | -9.4% | 8.0% | 8.8% | 5.9% | 11.8% | 7.0% | 10.1% | 18.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | 0.5 | 0.6 | 2.4 | 2.9 | 0.5 | -5.1 | -1.5 | -1.9 | 69 | 56 | -8.2 | -16 | 0.3 | 9.9 | 11 | 17 | 21 | 24 | 14 | 6.3 | 17,802 | 6.6 | -32 | -76 | -108 | -133 | -157 | -156 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.8 | -0.1 | 0.0 | 0.0 | 0.5 | 0.4 | -0.1 | -0.1 | – | – | – | – | 1.8 | – | – | 4.9 | 2,238.8 | 0.0 | -0.1 | -0.3 | -0.3 | -0.5 | -0.5 | -0.4 | |
| 87.4% | 77.3% | – | – | – | – | 91.0% | 88.9% | 66.7% | 62.6% | 56.3% | 50.1% | 43.3% | 30.4% | 28.1% | 45.0% | 77.1% | 27.8% | 87.3% | 87.1% | 88.8% | 29.1% | 86.3% | 60.3% | 25.4% | 22.2% | 21.5% | 21.2% | 18.7% | 15.4% | 15.6% | 14.9% | 18.2% | 22.3% | 25.9% | 28.0% | 32.9% | 35.9% | 36.2% | 40.9% | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.5 | 0.9 | 1.6 | 0.9 | 0.1 | 0.2 | 0.0 | 0.0 | 1.0 | 0.8 | 0.1 | 0.1 | 0.3 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | 0.7 | 0.8 | 223.7 | 0.3 | 0.3 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.49 | -0.32 | – | – | – | -553.70 | -0.60 | 1.31 | 0.63 | 0.52 | 0.60 | -0.54 | -0.72 | -0.90 | -1.02 | -0.76 | -0.03 | 0.06 | 9.56 | 16.35 | 29.52 | 22.87 | 29.42 | 16.23 | -91.46 | -84.28 | -94.90 | -97.15 | -4.19 | -10.86 | -8.92 | -7.62 | -5.52 | 10.23 | 11.48 | 7.56 | 15.89 | 8.95 | 13.43 | 25.62 | |
| 1.95 | 2.13 | – | – | – | 2,759.60 | 0.48 | 0.23 | 0.01 | 0.01 | 0.01 | 0.04 | 0.13 | 0.19 | 0.28 | 0.32 | 0.27 | 0.17 | 27.55 | 43.35 | 73.11 | 62.30 | 81.81 | 73.92 | 52.87 | 44.60 | 42.28 | 45.09 | 52.26 | 58.74 | 56.31 | 55.47 | 39.17 | 94.11 | 106.66 | 120.12 | 136.70 | 121.94 | 122.60 | 120.59 | |
| 1.47 | 1.34 | – | – | – | – | 2.14 | 1.64 | 0.35 | 0.29 | 0.21 | 0.23 | 0.19 | 0.14 | 0.34 | 0.69 | 1.04 | 0.13 | 16.78 | 17.04 | 18.71 | 29.01 | 18.20 | 121.99 | 25.51 | 19.49 | 19.93 | 21.16 | 20.28 | 14.58 | 13.71 | 12.61 | 10.70 | 28.69 | 33.68 | 35.67 | 44.19 | 45.90 | 48.25 | 56.16 | |
| – | – | – | – | – | -497.50 | -0.10 | -0.14 | -0.13 | – | – | – | – | – | -0.76 | -0.67 | -0.47 | -0.02 | -2.40 | -2.74 | 2.57 | 13.48 | 20.49 | 21.45 | 13.51 | 7.32 | 1.18 | -1.64 | 1.15 | -1.95 | -0.57 | 2.65 | 2.72 | 4.09 | 11.86 | 12.62 | 24.56 | 34.22 | 37.48 | 39.05 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.